Category Archives: Cell Therapy

Contact Information Available for logged-in reporters only Newswise Charlottesville, VA (July 8, 2014). A spinal mass was identified in a young woman with complete spinal cord injury 8 years after she had undergone implantation of olfactory mucosal cells in the hopes of regaining sensory and motor function. The case is reported and discussed in Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient. Case report, by Brian J. Dlouhy, MD, Olatilewa Awe, MD, Rajesh C. Rao, MD, Patricia A. Kirby, MD, and Patrick W. Hitchon, MD, published today online, ahead of print, in the Journal of Neurosurgery: Spine (http://thejns.org/doi/full/10.3171/2014.5.SPINE13992). The authors state that this is the first report of a spinal cord mass arising from spinal cord cell transplantation and neural stem cell therapy, and they caution that physicians should be vigilant in their follow-up of patients who undergo stem cell interventions. In its natural state, the olfactory mucosa lines the roof of the nasal cavity, adjacent to the respiratory mucosa that lines the lower nasal cavity. In addition to smell receptor neurons, the olfactory mucosa contains progenitor cells (also known as adult stem cells) and olfactory ensheathing cellsboth of which have been shown … Continue reading →

Theme: Uncover the potential that lies within the cell Welcome Message OMICS is engraving the marks of success in Open Access publishing and International scientific conferences. Inheritance of the research theme and flow of the scientific ideas through organized and clustered scientific session is the key in every OMICS Group conference.OMICS Group have 350leading-edge peer reviewed Open Access Journals and will be organizing over 100International Conferencesannually all over the world. OMICS Publishing Group Journals wrap over3 millionreaders with the well-built editorial board over30000eminent personalities. OMICS Group work together with more than100International Societiesand organizes symposia & workshops at the conferences. OMICS Group Conferences makes a furnish podium for global networking. 3rd InternationalConferenceand Exhibition on Cell & Gene Therapyto be held during October 27-29, 2014 at Las Vegas, USA. Cell Therapy conference is a remarkable event which brings together a unique and International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with Ph.D. Students. The combination of such diverse mix of people but everyone from the scientific field makes the necessary impact for the needed communication. Cell Therapy conference serves and … Continue reading →

CELL THERAPY MIXTAPE MUSIC BY KRUBRED NUFZLLENOD. By: Krubred Nufzellnod … Continue reading →

When an aging Hollywood action star or sex symbol reemerges after a long hiatus looking younger, with a great body and smoother, firmer facial skin, people now assume they have undergone stem cell therapy. In my interview with doctors Eric and Anna Yalung of Regenestem Manila, they set me straight. While the actor/actress may have had stem cell therapy, the outward appearance is most likely a combination of Botox, plastic surgery, a strict diet and a personal trainer. So no doctor who only offers you stem cell can promise you outwardly beautifying results. This is not to say though that there are no beauty benefits from it. For the beauty aspect, they do this for facial skin rejuvenation and hair growth. According to head dermatologist Anna Yalung, they inject the target area and, if necessary, combine it with services available at the clinic for best results and to speed up the process. Shots are spaced a week to a month apart depending on treatment requirement for three sessions. The follow-up is scheduled the following year. How is it done? Platelet Rich Plasma (PRP) is a convenient and cell-based treatment. It is a simple procedure involving the extraction of blood, separation … Continue reading →

ACGT president and co-founder, Barbara Netter, at left, with Savio L.C. Woo, founding chair, ACGT Scientific Advisory Council and professor at the Mt. Sinai School of Medicine. Barbara Netter and her late husband Edward Netter have been awarded the American Society of Gene and Cell Therapy (ASGCT) Distinguished Service Award for their contributions to the field of genetic and cellar therapy. As the founders of Alliance for Cancer Gene Therapy (ACGT), the Netters have helped grant almost $25 million in funding to cancer researchers and physicians worldwide. The award was presented during the 17th annual meeting of the ASGCT May 22, in front of some 1,700 scientists and cancer research advocates. Its an honor to receive this accolade from an organization at the center of our medical community, Ms. Netter said in a statement. Through the work at ACGT and in the cell and gene therapy realm, I have the rare opportunity to see new and optimistic methods of treating cancer unfold. With fantastic breakthroughs in cancer cell and gene therapy occurring more frequently, the future is bright. Founded in 1998, the ASGCT is a non-profit medical organization dedicated to boosting awareness for gene and cell therapies. These therapies have … Continue reading →

How to Grow Your Hair Faster and Longer: Ovation Cell Therapy Here is a review/how to on how i've been growing my hair with ovation cell hair therapy. I cut 6.5 inches in december which was A LOT! So now I'm on the trac... By: Vanessa Watson … Continue reading →

The Cell Therapy Catapult Official Opening Event The Cell Therapy Catapult official opening event was a great succes with many colleagues from industry, government and universities attending including RT Hon Dr. Vince Cable MP, Secretary... By: Cell Therapy Catapult … Continue reading →

A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study provides the technical solution to identify mutated tumor targets that can stimulate immune responses, which is one of the major bottlenecks in developing a new generation of adoptive T-cell therapy," said Steven A. Rosenberg, MD, PhD, chief of surgery at the National Cancer Institute (NCI) in Bethesda, Maryland. "The two targets identified in this study play important roles in cancer cell proliferation. "Immunotherapy has the potential to successfully treat cancer by targeting tumor mutations. We've moved one step closer because of this study," Rosenberg added. Adoptive T-cell therapy is a type of immunotherapy in which the immune cells infiltrating a patient's tumor, so called tumor-infiltrating lymphocytes (TILs, which are T cells), are harvested, activated and expanded in the laboratory, and transferred back to the patient. Such activated cells are capable of efficiently attacking tumor cells. "In … Continue reading →

PUBLIC RELEASE DATE: 1-Jul-2014 Contact: Jeremy Moore jeremy.moore@aacr.org 215-446-7109 American Association for Cancer Research PHILADELPHIA A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study provides the technical solution to identify mutated tumor targets that can stimulate immune responses, which is one of the major bottlenecks in developing a new generation of adoptive T-cell therapy," said Steven A. Rosenberg, MD, PhD, chief of surgery at the National Cancer Institute (NCI) in Bethesda, Maryland. "The two targets identified in this study play important roles in cancer cell proliferation. "Immunotherapy has the potential to successfully treat cancer by targeting tumor mutations. We've moved one step closer because of this study," Rosenberg added. Adoptive T-cell therapy is a type of immunotherapy in which the immune cells infiltrating a patient's tumor, so called tumor-infiltrating lymphocytes (TILs, which are T cells), are harvested, activated and expanded in the laboratory, and transferred … Continue reading →

Study shows promise for virus specific T cell therapy following bone marrow transplant Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital published new res... By: BCMweb … Continue reading →